Amicus Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2004
Revenue	399.36	329.23	305.51	260.89	182.24	91.25	36.93	4.96	0	1.22	Upgrade
Revenue Growth (YoY)	21.30%	7.76%	17.11%	43.16%	99.72%	147.08%	644.86%	-	-	237.19%	Upgrade
Cost of Revenue	37.33	38.6	34.47	31.04	21.96	14.4	6.24	0.83	0	0	Upgrade
Gross Profit	362.03	290.63	271.05	229.84	160.27	76.84	30.69	4.13	0	1.22	Upgrade
Selling, General & Admin	275.27	213.04	192.71	156.41	169.86	127.2	88.67	71.15	47.27	20.72	Upgrade
Research & Development	152.38	276.68	272.05	308.44	286.38	270.9	149.31	104.79	76.94	47.62	Upgrade
Other Operating Expenses	9.01	11.96	6.21	8.85	4.78	4.22	469.02	3.31	1.85	1.48	Upgrade
Operating Expenses	436.66	501.68	470.97	473.7	461.01	402.32	707	179.26	126.06	69.83	Upgrade
Operating Income	-74.63	-211.04	-199.92	-243.85	-300.74	-325.48	-676.31	-175.13	-126.06	-68.6	Upgrade
Interest Expense / Income	50.15	37.12	32.47	22.43	18.87	22.4	17.24	5.4	1.58	1.48	Upgrade
Other Expense / Income	25.32	-6.12	9.16	7.98	36.3	1.21	-244.43	23.25	4.48	-0.05	Upgrade
Pretax Income	-150.1	-242.04	-241.55	-274.25	-355.91	-349.09	-449.12	-203.78	-132.12	-70.04	Upgrade
Income Tax	1.48	-5.47	8.91	2.6	0.48	-0.09	-165.12	-3.74	0	-1.11	Upgrade
Net Income	-151.58	-236.57	-250.46	-276.85	-356.39	-349	-284	-200.04	-132.12	-68.93	Upgrade
Shares Outstanding (Basic)	295	289	271	259	240	186	153	134	110	74	Upgrade
Shares Outstanding (Diluted)	295	289	271	259	240	186	153	134	110	74	Upgrade
Shares Change	2.11%	6.50%	4.85%	7.67%	29.40%	21.15%	14.10%	22.27%	47.66%	45.15%	Upgrade
EPS (Basic)	-0.51	-0.82	-0.92	-1.07	-1.48	-1.88	-1.85	-1.49	-1.20	-0.93	Upgrade
EPS (Diluted)	-0.51	-0.82	-0.92	-1.07	-1.48	-1.88	-1.85	-1.49	-1.20	-0.93	Upgrade
Free Cash Flow	-76.53	-166.93	-206.38	-236.52	-270.43	-306.26	-218.22	-156.1	-104.96	-51.91	Upgrade
Free Cash Flow Per Share	-0.26	-0.58	-0.76	-0.91	-1.13	-1.65	-1.42	-1.16	-0.95	-0.70	Upgrade
Gross Margin	90.65%	88.28%	88.72%	88.10%	87.95%	84.21%	83.11%	83.20%	-	100.00%	Upgrade
Operating Margin	-18.69%	-64.10%	-65.44%	-93.47%	-165.03%	-356.71%	-1831.32%	-3532.27%	-	-5604.66%	Upgrade
Profit Margin	-37.96%	-71.85%	-81.98%	-106.12%	-195.56%	-382.48%	-769.03%	-4034.73%	-	-5631.21%	Upgrade
Free Cash Flow Margin	-19.16%	-50.70%	-67.55%	-90.66%	-148.39%	-335.65%	-590.90%	-3148.41%	-	-4240.77%	Upgrade
EBITDA	-92.08	-199.58	-202.87	-242.98	-332.26	-322.47	-428.29	-195.14	-128.71	-67.01	Upgrade
EBITDA Margin	-23.06%	-60.62%	-66.40%	-93.14%	-182.32%	-353.41%	-1159.73%	-3935.88%	-	-5474.51%	Upgrade
Depreciation & Amortization	7.87	5.34	6.21	8.85	4.78	4.22	3.59	3.24	1.83	1.55	Upgrade
EBIT	-99.95	-204.92	-209.08	-251.83	-337.04	-326.69	-431.88	-198.38	-130.54	-68.56	Upgrade
EBIT Margin	-25.03%	-62.24%	-68.44%	-96.53%	-184.94%	-358.03%	-1169.46%	-4001.27%	-	-5600.90%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).